In summary, these findings demonstrate that using multiple features derived from the FV protein is a powerful strategy to anticipate the risk of FV-deficiency in patients harboring non-synonymous mutations. The gene discussed is F5; the disease is hyperinsulinemic hypoglycemia, familial, 4.